This federal contract award is for a Small Business Innovation Research (SBIR) Phase I project from the Defense Health Agency (DHA) to Emergingdx Inc., a small business subchapter S corporation based in Mansfield, Massachusetts. The contract, valued at $249,993.61, supports the development of a "Rapid, Automated, Multiplexed Omics Platform" for medical research and diagnostic applications. As a total small business set-aside contract, this award demonstrates Emergingdx Inc.'s expertise in developing advanced diagnostic and biosensor technologies, particularly for defense and civilian healthcare markets. The company has received multiple SBIR and Small Business Technology Transfer (STTR) contracts from agencies such as the DHA and Office of Naval Research, focused on innovative diagnostic solutions across medical and agricultural domains.
Generated 2/4/25, 10:18 AM